|Bid||0.4100 x 0|
|Ask||0.4250 x 0|
|Day's Range||0.3900 - 0.4300|
|52 Week Range||0.2730 - 0.6050|
|Beta (5Y Monthly)||0.01|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 29, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Bond investors aren’t too optimistic about higher oil prices lifting the prospects of the weakest U.S. energy companies, where defaults have been climbing.
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
HMS Holdings Corp. (HMSY), a leading U.S.-based provider of healthcare technology, analytics and engagement solutions, today announced that HMS, through a subsidiary, will make a strategic investment of $7.5 million (US) in ordinary shares of MedAdvisor Limited (ASX:MDR), Australia’s leading digital medication management company. HMS intends to fund the investment with cash on hand. Upon completion of the transaction, HMS will hold an approximate 13% ownership stake in MedAdvisor.
In 2015 Robert Read was appointed CEO of MedAdvisor Limited (ASX:MDR). This report will, first, examine the CEO...
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! The big shareholder groups in MedAdvisor Limited (ASX:MDR) have power over the company. Institut...
MedAdvisor International to Present at the Planet MicroCap Showcase 2019 on May 1 in Las Vegas, NV MELBOURNE, AUSTRALIA / ACCESSWIRE / April 23, 2019 / MedAdvisor International (ASX: MDR) , Australia's ...